Literature DB >> 17401438

Histamine H3-receptor agonists and imidazole-based H3-receptor antagonists can be thermodynamically discriminated.

E A Harper1, J W Black.   

Abstract

BACKGROUND AND
PURPOSE: Studies suggest that measurement of thermodynamic parameters can allow discrimination of agonists and antagonists. Here we investigate whether agonists and antagonists can be thermodynamically discriminated at histamine H(3) receptors. EXPERIMENTAL APPROACH: The pK(L) of the antagonist radioligand, [(3)H]-clobenpropit, in guinea-pig cortex membranes was estimated at 4, 12, 21 and 30 degrees C in 20 mM HEPES-NaOH buffer (buffer A), or buffer A containing 300 mM CaCl(2), (buffer A(Ca)). pK(I)' values for ligands with varying intrinsic activity were determined in buffer A and A(Ca) at 4, 12, 21 and 30 degrees C. KEY
RESULTS: In buffer A, the pK(L) of [(3)H]-clobenpropit increased with decreasing temperature while it did not change in buffer A(Ca). The Bmax was not affected by temperature or buffer and n (H) values were not different from unity. In buffer A, pK(I)' values for agonists remained unchanged or decreased with decreasing temperature, while antagonist pK(I) values increased with decreasing temperature; agonist binding was entropy-driven while antagonist binding was enthalpy and entropy-driven. In buffer A(Ca), temperature had no effect on antagonist and agonist pK(I) values; both agonist and antagonist binding were enthalpy and entropy-driven. CONCLUSIONS AND IMPLICATIONS: The binding of H(3)-receptor agonists and antagonists can be thermodynamically discriminated under conditions where agonist pK(I)' values are over-estimated (pK(I)' not = pK(app)). However, under conditions when agonist pK(I) approximately pK(app), the thermodynamics underlying the binding of agonists are not different to those of antagonists.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401438      PMCID: PMC2013973          DOI: 10.1038/sj.bjp.0707243

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

1.  Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor.

Authors:  G A Weiland; K P Minneman; P B Molinoff
Journal:  Nature       Date:  1979-09-13       Impact factor: 49.962

2.  Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.

Authors:  Tibor Mikó; Xavier Ligneau; Heinz H Pertz; C Robin Ganellin; Jean-Michel Arrang; Jean-Charles Schwartz; Walter Schunack; Holger Stark
Journal:  J Med Chem       Date:  2003-04-10       Impact factor: 7.446

3.  The kinetics of competitive radioligand binding predicted by the law of mass action.

Authors:  H J Motulsky; L C Mahan
Journal:  Mol Pharmacol       Date:  1984-01       Impact factor: 4.436

4.  Agonist and antagonist benzodiazepine receptor interaction in vitro.

Authors:  H Möhler; J G Richards
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

5.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

6.  A new class of diamine-based human histamine H3 receptor antagonists: 4-(aminoalkoxy)benzylamines.

Authors:  Richard Apodaca; Curt A Dvorak; Wei Xiao; Ann J Barbier; Jamin D Boggs; Sandy J Wilson; Timothy W Lovenberg; Nicholas I Carruthers
Journal:  J Med Chem       Date:  2003-08-28       Impact factor: 7.446

7.  Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists.

Authors:  Tibor Mikó; Xavier Ligneau; Heinz H Pertz; Jean-Michel Arrang; C Robin Ganellin; Jean-Charles Schwartz; Walter Schunack; Holger Stark
Journal:  Bioorg Med Chem       Date:  2004-05-15       Impact factor: 3.641

8.  Non-imidazole heterocyclic histamine H3 receptor antagonists.

Authors:  Wenying Chai; J Guy Breitenbucher; Annette Kwok; Xiaobing Li; Victoria Wong; Nicholas I Carruthers; Timothy W Lovenberg; Curt Mazur; Sandy J Wilson; Frank U Axe; Todd K Jones
Journal:  Bioorg Med Chem Lett       Date:  2003-05-19       Impact factor: 2.823

9.  1-alkyl-4-acylpiperazines as a new class of imidazole-free histamine H(3) receptor antagonists.

Authors:  Florencio Zaragoza; Henrik Stephensen; Sanne M Knudsen; Lone Pridal; Birgitte S Wulff; Karin Rimvall
Journal:  J Med Chem       Date:  2004-05-20       Impact factor: 7.446

10.  Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.

Authors:  N R Zahniser; P B Molinoff
Journal:  Mol Pharmacol       Date:  1983-03       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.